%0 Journal Article
%T [18F]Fludarabine-PET as a promising tool for differentiating CNS lymphoma and glioblastoma: Comparative analysis with [18F]FDG in human xenograft models
%A Benoit Plancoulaine
%A Fabien Fillesoye
%A Fabienne Gourand
%A J¨¦r£¿me Toutain
%A Louisa Barr¨¦
%A M¨¦ziane Ibazizene
%A Narin¨¦e Hovhannisyan
%A Samuel Valable
%A St¨¦phane Guillouet
%J Theranostics
%D 2018
%I Ivyspring International Publisher
%R 10.7150/thno.26754
%X This paper investigated whether positron emission tomography (PET) imaging with [18F]fludarabine ([18F]FDB) can help to differentiate central nervous system lymphoma (CNSL) from glioblastoma (GBM), which is a crucial issue in the diagnosis and management of patients with these aggressive brain tumors. Multimodal analyses with [18F]fluorodeoxyglucose ([18F]FDG), magnetic resonance imaging (MRI) and histology have also been considered to address the specificity of [18F]FDB for CNSL.
%K [18F]fludarabine-PET
%K [18F]FDG
%K CNS lymphoma
%K glioblastoma
%K differential diagnosis
%U http://www.thno.org/v08p4563.htm